SCHEMBL20201475

SCHEMBL20201475

Cc1cccc(N2CN(C)c3cncnc32)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
ALDH1A1 P00352 5/20 0.39
CYP3A4 P08684 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
TSHR P16473 2/20 0.36
RECQL P46063 1/20 0.36
ADRB1 P08588 1/20 0.35
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
FNTA P49354 2/20 0.34
FNTB P49356 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201472 0.89 MAPT (0.41) MAPTALDH1A1CYP3A4MEN1KMT2A
SCHEMBL17754705 0.89 CYP1A2 (0.44) MAPTALDH1A1CYP3A4MEN1KMT2A
SCHEMBL20201470 0.81 GAA (0.46) MAPTALDH1A1CYP3A4KMT2ACYP2C19
SCHEMBL20201469 0.77 CYP3A4 (0.41) MAPTALDH1A1CYP3A4KMT2ACYP2C19
SCHEMBL20201474 0.77 CYP3A4 (0.41) MAPTALDH1A1CYP3A4KMT2ACYP2C19
SCHEMBL17754709 0.77 CYP1A2 (0.44) ALDH1A1CYP3A4MEN1KMT2ACYP2C19
SCHEMBL20201473 0.77 CYP3A4 (0.43) MAPTALDH1A1CYP3A4MEN1KMT2A
SCHEMBL24981453 0.76 CYP1A2 (0.40) MAPTALDH1A1CYP3A4MEN1KMT2A
SCHEMBL20201468 0.74 CYP3A4 (0.44) MAPTALDH1A1CYP3A4MEN1KMT2A
SCHEMBL20201466 0.72 GAA (0.49) MAPTCYP3A4KMT2ACYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180151816-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES TEC, EML4, TPR MAPT 230/4885ALDH1A1 2604/4885CYP3A4 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.